Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Humans (2)
- Adjuvants (1)
- Adjuvants, Immunologic (1)
- Adult (1)
- Animals (1)
-
- COVID-19 Vaccines (1)
- Chemokines (1)
- Combined (1)
- Dendritic cells (1)
- Ectromelia virus (1)
- Immunoglobulin G (1)
- Immunologic (1)
- Infant (1)
- Innate immunity (1)
- Ligands (1)
- Lipid A (1)
- MRNA Vaccines (1)
- Messenger (1)
- Mice (1)
- Monocytes (1)
- Natural killer cells (1)
- Pandemics (1)
- RNA (1)
- RNA, Messenger (1)
- Toll-Like Receptor 4 (1)
- Toll-like receptor 4 (1)
- United States (1)
- Vaccines (1)
- Vaccines, Combined (1)
Articles 1 - 3 of 3
Full-Text Articles in Microbiology
Monophosphoryl Lipid A-Based Adjuvant To Promote The Immunogenicity Of Multivalent Meningococcal Polysaccharide Conjugate Vaccines, Kishore Alugupalli
Monophosphoryl Lipid A-Based Adjuvant To Promote The Immunogenicity Of Multivalent Meningococcal Polysaccharide Conjugate Vaccines, Kishore Alugupalli
Department of Microbiology and Immunology Faculty Papers
Activation of the adaptive immune system requires the engagement of costimulatory pathways in addition to B and T cell Ag receptor signaling, and adjuvants play a central role in this process. Many Gram-negative bacterial polysaccharide vaccines, including the tetravalent meningococcal conjugate vaccines (MCV4) and typhoid Vi polysaccharide vaccines, do not incorporate adjuvants. The immunogenicity of typhoid vaccines is due to the presence of associated TLR4 ligands in these vaccines. Because the immunogenicity of MCV4 is poor and requires boosters, I hypothesized that TLR4 ligands are absent in MCV4 and that incorporation of a TLR4 ligand-based adjuvant would improve their immunogenicity. …
The Mrna-Lnp Vaccines - The Good, The Bad And The Ugly?, Botond Z. Igyártó, Zhen Qin
The Mrna-Lnp Vaccines - The Good, The Bad And The Ugly?, Botond Z. Igyártó, Zhen Qin
Department of Microbiology and Immunology Faculty Papers
The mRNA-LNP vaccine has received much attention during the COVID-19 pandemic since it served as the basis of the most widely used SARS-CoV-2 vaccines in Western countries. Based on early clinical trial data, these vaccines were deemed safe and effective for all demographics. However, the latest data raise serious concerns about the safety and effectiveness of these vaccines. Here, we review some of the safety and efficacy concerns identified to date. We also discuss the potential mechanism of observed adverse events related to the use of these vaccines and whether they can be mitigated by alterations of this vaccine mechanism …
Defective Early Innate Immune Response To Ectromelia Virus In The Draining Lymph Nodes Of Aged Mice Due To Impaired Dendritic Cell Accumulation., Colby Stotesbury, Eric B Wong, Lingjuan Tang, Brian Montoya, Cory J Knudson, Carolina R Melo-Silva, Luis J Sigal
Defective Early Innate Immune Response To Ectromelia Virus In The Draining Lymph Nodes Of Aged Mice Due To Impaired Dendritic Cell Accumulation., Colby Stotesbury, Eric B Wong, Lingjuan Tang, Brian Montoya, Cory J Knudson, Carolina R Melo-Silva, Luis J Sigal
Department of Microbiology and Immunology Faculty Papers
It is known that aging decreases natural resistance to viral diseases due to dysfunctional innate and adaptive immune responses, but the nature of these dysfunctions, particularly in regard to innate immunity, is not well understood. We have previously shown that C57BL/6J (B6) mice lose their natural resistance to footpad infection with ectromelia virus (ECTV) due to impaired maturation and recruitment of natural killer (NK) cells to the draining popliteal lymph node (dLN). More recently, we have also shown that in young B6 mice infected with ECTV, the recruitment of NK cells is dependent on a complex cascade whereby migratory dendritic …